Last Price
9.90
Today's Change
+0.33 (3.44%)
Day's Change
9.70 - 12.00
Trading Volume
4,031,910
Market Cap
358 Million
Shares Outstanding
36 Million
Avg Volume
736,858
Avg Price (50 Days)
6.75
Avg Price (200 Days)
11.20
PE Ratio
-2.54
EPS
-3.90
Earnings Announcement
29-Oct-2024
Previous Close
9.57
Open
11.48
Day's Range
9.7 - 12.0091
Year Range
3.61 - 22.74
Trading Volume
4,031,910
1 Day Change
3.45%
5 Day Change
13.01%
1 Month Change
31.30%
3 Month Change
120.00%
6 Month Change
-33.78%
Ytd Change
-32.52%
1 Year Change
-26.34%
3 Year Change
-9.17%
5 Year Change
-41.76%
10 Year Change
-41.76%
Max Change
-41.76%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.